Search Browse Earnings

Talis Biomedical Corp — SlamSEC

Talis Biomedical Corp

OTC:TLIS

Laboratory Analytical Instruments·CHICAGO, IL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CFO

Markovich Rebecca

Revenue

$4.8M

-41.3% YoY

FY 2023

Adj. EBITDA

-$106.3M

-2209.2% margin

FY 2023

Net Income

-$113.0M

-2348.5% margin

FY 2023

EPS (Diluted)

-$62.77

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$130.2M

FY 2023

Total Debt

—

Net Cash

$130.2M

FY 2023

Enterprise Value

—

Debt / EBITDA

1.2x

FY 2023

EV / EBITDA

—

Employees

—